Hardware, Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
TEL vs BDC vs APH vs GLW vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Communication Equipment
Hardware, Equipment & Parts
Hardware, Equipment & Parts
Industrial - Machinery
TEL vs BDC vs APH vs GLW vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Communication Equipment | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Industrial - Machinery |
| Market Cap | $61.60B | $4.37B | $167.94B | $156.70B | $79.02B |
| Revenue (TTM) | $18.52B | $2.79B | $25.90B | $16.32B | $18.32B |
| Net Income (TTM) | $2.91B | $237M | $4.48B | $1.81B | $2.44B |
| Gross Margin | 35.4% | 35.8% | 37.3% | 36.3% | 52.7% |
| Operating Margin | 19.3% | 12.3% | 26.0% | 15.3% | 19.8% |
| Forward P/E | 18.7x | 14.2x | 29.3x | 57.8x | 21.7x |
| Total Debt | $6.55B | $1.47B | $15.50B | $10.22B | $13.76B |
| Cash & Equiv. | $1.25B | $390M | $11.13B | $1.53B | $1.54B |
TEL vs BDC vs APH vs GLW vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| TE Connectivity Ltd. (TEL) | 100 | 258.4 | +158.4% |
| Belden Inc. (BDC) | 100 | 329.6 | +229.6% |
| Amphenol Corporation (APH) | 100 | 565.9 | +465.9% |
| Corning Incorporated (GLW) | 100 | 800.4 | +700.4% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TEL vs BDC vs APH vs GLW vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, TEL doesn't own a clear edge in any measured category.
BDC is the #2 pick in this set and the best alternative if sleep-well-at-night and valuation efficiency is your priority.
- Lower volatility, beta 1.41, current ratio 1.93x
- PEG 0.38 vs EMR's 4.81
- Beta 1.41, yield 0.2%, current ratio 1.93x
- Lower P/E (14.2x vs 21.7x), PEG 0.38 vs 4.81
APH carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 51.7%, EPS growth 74.0%, 3Y rev CAGR 22.3%
- 51.7% revenue growth vs EMR's 3.0%
- 17.3% margin vs BDC's 8.5%
- 13.6% ROA vs EMR's 5.8%, ROIC 28.3% vs 8.2%
GLW ranks third and is worth considering specifically for long-term compounding.
- 9.4% 10Y total return vs APH's 9.0%
- +309.2% vs BDC's +7.0%
EMR is the clearest fit if your priority is income & stability.
- Dividend streak 37 yrs, beta 1.52, yield 1.5%
- 1.5% yield, 37-year raise streak, vs APH's 0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 51.7% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (14.2x vs 21.7x), PEG 0.38 vs 4.81 | |
| Quality / Margins | 17.3% margin vs BDC's 8.5% | |
| Stability / Safety | Beta 1.41 vs GLW's 1.90 | |
| Dividends | 1.5% yield, 37-year raise streak, vs APH's 0.5% | |
| Momentum (1Y) | +309.2% vs BDC's +7.0% | |
| Efficiency (ROA) | 13.6% ROA vs EMR's 5.8%, ROIC 28.3% vs 8.2% |
TEL vs BDC vs APH vs GLW vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TEL vs BDC vs APH vs GLW vs EMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
APH leads in 2 of 6 categories
BDC leads 1 • GLW leads 1 • EMR leads 1 • TEL leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
APH leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
APH is the larger business by revenue, generating $25.9B annually — 9.3x BDC's $2.8B. APH is the more profitable business, keeping 17.3% of every revenue dollar as net income compared to BDC's 8.5%. On growth, APH holds the edge at +58.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $18.5B | $2.8B | $25.9B | $16.3B | $18.3B |
| EBITDAEarnings before interest/tax | $4.3B | $475M | $7.9B | $3.5B | $4.7B |
| Net IncomeAfter-tax profit | $2.9B | $237M | $4.5B | $1.8B | $2.4B |
| Free Cash FlowCash after capex | $3.4B | $180M | $4.6B | $1.5B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +35.4% | +35.8% | +37.3% | +36.3% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +19.3% | +12.3% | +26.0% | +15.3% | +19.8% |
| Net MarginNet income ÷ Revenue | +15.7% | +8.5% | +17.3% | +11.1% | +13.3% |
| FCF MarginFCF ÷ Revenue | +18.3% | +6.5% | +17.9% | +9.2% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.5% | +11.4% | +58.4% | +20.0% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +66.0% | +2.4% | +24.1% | +138.9% | +28.2% |
Valuation Metrics
BDC leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 19.0x trailing earnings, BDC trades at a 81% valuation discount to GLW's 98.6x P/E. Adjusting for growth (PEG ratio), BDC offers better value at 0.51x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $61.6B | $4.4B | $167.9B | $156.7B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $66.9B | $5.5B | $172.3B | $165.4B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | 34.08x | 18.98x | 40.90x | 98.60x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.72x | 14.16x | 29.29x | 57.80x | 21.71x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.51x | 1.47x | 3.53x | 7.73x |
| EV / EBITDAEnterprise value multiple | 16.52x | 11.82x | 24.99x | 44.97x | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 3.60x | 1.61x | 7.27x | 10.03x | 4.39x |
| Price / BookPrice ÷ Book value/share | 4.93x | 3.57x | 12.92x | 12.75x | 3.94x |
| Price / FCFMarket cap ÷ FCF | 19.23x | 19.97x | 38.36x | 110.90x | 29.63x |
Profitability & Efficiency
APH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
APH delivers a 34.6% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $12 for EMR. TEL carries lower financial leverage with a 0.51x debt-to-equity ratio, signaling a more conservative balance sheet compared to BDC's 1.17x. On the Piotroski fundamental quality scale (0–9), BDC scores 7/9 vs TEL's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +22.5% | +18.8% | +34.6% | +15.0% | +12.1% |
| ROA (TTM)Return on assets | +11.5% | +6.8% | +13.6% | +6.0% | +5.8% |
| ROICReturn on invested capital | +14.1% | +11.0% | +28.3% | +9.1% | +8.2% |
| ROCEReturn on capital employed | +16.9% | +12.0% | +25.5% | +9.7% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.51x | 1.17x | 1.15x | 0.83x | 0.68x |
| Net DebtTotal debt minus cash | $5.3B | $1.1B | $4.4B | $8.7B | $12.2B |
| Cash & Equiv.Liquid assets | $1.3B | $390M | $11.1B | $1.5B | $1.5B |
| Total DebtShort + long-term debt | $6.5B | $1.5B | $15.5B | $10.2B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 31.48x | 6.89x | 13.54x | 7.90x | 6.46x |
Total Returns (Dividends Reinvested)
GLW leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in APH five years ago would be worth $40,876 today (with dividends reinvested), compared to $15,945 for EMR. Over the past 12 months, GLW leads with a +309.2% total return vs BDC's +7.0%. The 3-year compound annual growth rate (CAGR) favors GLW at 80.7% vs BDC's 11.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.7% | -4.7% | -2.0% | +101.5% | +4.3% |
| 1-Year ReturnPast 12 months | +42.1% | +7.0% | +70.0% | +309.2% | +30.4% |
| 3-Year ReturnCumulative with dividends | +77.5% | +40.3% | +267.6% | +490.3% | +75.9% |
| 5-Year ReturnCumulative with dividends | +60.9% | +109.7% | +308.8% | +308.4% | +59.5% |
| 10-Year ReturnCumulative with dividends | +291.2% | +91.1% | +899.3% | +944.3% | +206.6% |
| CAGR (3Y)Annualised 3-year return | +21.1% | +11.9% | +54.3% | +80.7% | +20.7% |
Risk & Volatility
Evenly matched — BDC and GLW each lead in 1 of 2 comparable metrics.
Risk & Volatility
BDC is the less volatile stock with a 1.41 beta — it tends to amplify market swings less than GLW's 1.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GLW currently trades 93.2% from its 52-week high vs BDC's 70.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.58x | 1.41x | 1.62x | 1.90x | 1.52x |
| 52-Week HighHighest price in past year | $252.56 | $159.99 | $167.04 | $195.81 | $165.15 |
| 52-Week LowLowest price in past year | $147.80 | $103.57 | $79.27 | $44.33 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +83.1% | +70.1% | +81.8% | +93.2% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 49.8 | 38.3 | 45.1 | 64.3 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 2.3M | 379K | 8.3M | 11.0M | 2.8M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TEL as "Buy", BDC as "Buy", APH as "Buy", GLW as "Buy", EMR as "Buy". Consensus price targets imply 33.7% upside for BDC (target: $150) vs -21.5% for GLW (target: $143). For income investors, EMR offers the higher dividend yield at 1.49% vs BDC's 0.18%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $262.57 | $150.00 | $180.33 | $143.11 | $161.92 |
| # AnalystsCovering analysts | 29 | 14 | 29 | 37 | 41 |
| Dividend YieldAnnual dividend ÷ price | +1.3% | +0.2% | +0.5% | +0.6% | +1.5% |
| Dividend StreakConsecutive years of raises | 15 | 0 | 15 | 1 | 37 |
| Dividend / ShareAnnual DPS | $2.69 | $0.20 | $0.63 | $1.16 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.2% | +5.0% | +0.4% | +0.1% | +1.6% |
APH leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BDC leads in 1 (Valuation Metrics). 1 tied.
TEL vs BDC vs APH vs GLW vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TEL or BDC or APH or GLW or EMR a better buy right now?
For growth investors, Amphenol Corporation (APH) is the stronger pick with 51.
7% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Belden Inc. (BDC) offers the better valuation at 19. 0x trailing P/E (14. 2x forward), making it the more compelling value choice. Analysts rate TE Connectivity Ltd. (TEL) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TEL or BDC or APH or GLW or EMR?
On trailing P/E, Belden Inc.
(BDC) is the cheapest at 19. 0x versus Corning Incorporated at 98. 6x. On forward P/E, Belden Inc. is actually cheaper at 14. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Belden Inc. wins at 0. 38x versus Emerson Electric Co. 's 4. 81x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — TEL or BDC or APH or GLW or EMR?
Over the past 5 years, Amphenol Corporation (APH) delivered a total return of +308.
8%, compared to +59. 5% for Emerson Electric Co. (EMR). Over 10 years, the gap is even starker: GLW returned +944. 3% versus BDC's +91. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TEL or BDC or APH or GLW or EMR?
By beta (market sensitivity over 5 years), Belden Inc.
(BDC) is the lower-risk stock at 1. 41β versus Corning Incorporated's 1. 90β — meaning GLW is approximately 35% more volatile than BDC relative to the S&P 500. On balance sheet safety, TE Connectivity Ltd. (TEL) carries a lower debt/equity ratio of 51% versus 117% for Belden Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TEL or BDC or APH or GLW or EMR?
By revenue growth (latest reported year), Amphenol Corporation (APH) is pulling ahead at 51.
7% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Corning Incorporated grew EPS 219. 0% year-over-year, compared to -40. 4% for TE Connectivity Ltd.. Over a 3-year CAGR, APH leads at 22. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TEL or BDC or APH or GLW or EMR?
Amphenol Corporation (APH) is the more profitable company, earning 18.
5% net margin versus 8. 7% for Belden Inc. — meaning it keeps 18. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: APH leads at 25. 9% versus 12. 2% for BDC. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TEL or BDC or APH or GLW or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Belden Inc. (BDC) is the more undervalued stock at a PEG of 0. 38x versus Emerson Electric Co. 's 4. 81x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Belden Inc. (BDC) trades at 14. 2x forward P/E versus 57. 8x for Corning Incorporated — 43. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BDC: 33. 7% to $150. 00.
08Which pays a better dividend — TEL or BDC or APH or GLW or EMR?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 2% for Belden Inc. (BDC).
09Is TEL or BDC or APH or GLW or EMR better for a retirement portfolio?
For long-horizon retirement investors, Corning Incorporated (GLW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0.
6% yield, +944. 3% 10Y return). Both have compounded well over 10 years (GLW: +944. 3%, BDC: +91. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TEL and BDC and APH and GLW and EMR?
These companies operate in different sectors (TEL (Technology) and BDC (Technology) and APH (Technology) and GLW (Technology) and EMR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TEL is a mid-cap quality compounder stock; BDC is a small-cap quality compounder stock; APH is a mid-cap high-growth stock; GLW is a mid-cap high-growth stock; EMR is a mid-cap quality compounder stock. TEL, GLW, EMR pay a dividend while BDC, APH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.